Google DeepMind launched AlphaGenome, an AI tool that identifies genetic mutations driving disease.
AlphaGenome predicts how DNA changes disrupt gene regulation across cells and tissues.
The tool analyses up to one million DNA letters at once.
Researchers trained it on human and mouse genetic databases.
Scientists link many diseases to regulatory mutations rather than protein-coding genes.
AlphaGenome helps pinpoint mutations behind cancer, heart disease, and autoimmune disorders.
Experts say it could accelerate drug discovery and gene therapy design.
Researchers at University College London and University of Exeter called it a major advance.
Google DeepMind Unveils AlphaGenome to Decode Genetic Disease Drivers
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
Add A Comment
Important Links
© 2026 Paris Paper. All Rights Reserved.